jamiebell

575 POSTS 0 COMMENTS

Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke

Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe. This is the first offering from...

Abbott gains US FDA approval for SCS therapy in painful diabetic...

Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful...

Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment

A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...

CELLO II balloon guide catheter gains US FDA approval for peripheral...

cello ii catheter
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can...

Blackford and Brainomix announce partnership to advance AI-assisted stroke care

Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...

Chinese MATCH study finds microsurgery is “dominant” brain AVM treatment

Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is...

Hospitals without high-level designation more likely to miss strokes following TAVI...

A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that...

ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...

Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...

Clinical trial to test novel wearable treatment for chronic pain and...

A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...

Novel digital intervention meets primary endpoint in chronic stroke trial

MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was...

Basecamp Vascular announces upcoming appointment of new CEO

Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023. He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild...

Challenging the status quo in stroke care

This advertorial is sponsored by Philips. Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...

AHA statement: Even transient stroke symptoms require emergency assessment

Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke,...

Squid liquid embolic agent deemed safe and effective for high-grade DAVFs

The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the...

Saluda Medical announces presentation of 36-month EVOKE trial data at NANS...

Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual...

Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study...

An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...

Abbott presents new data on streamlining patient-reported measures, BurstDR and more...

Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las...

Interventions—not neuroimaging—found to be driving increased ischaemic stroke costs

A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from...

Neuralace enrols first patients in AT-PDN study evaluating Axon therapy

Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study. The multicentre AT-PDN study...

Neuroprotection “renaissance” offers hope for improved stroke therapies in future

The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...

First human cases performed with high-frequency imaging offering “unprecedented potential” in...

vis-m neurovascular imaging
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...

Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms

A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...

Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of...

Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...

Medtronic to highlight sensing-enabled spinal cord stimulation research at NANS 2023

Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation...

So, you want to be a principal investigator?

A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and...

Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology

Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...

DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but...

A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December...

SynerFuse announces “milestone” solo spine surgeon procedure in DRG stimulation study

Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse...

Nalu Medical announces publication of two spinal cord stimulation clinical studies

Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve...

NeuroNews’ top 10 most popular stories of December 2022

The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around...

Mathematical model examines factors influencing risk of cerebral aneurysm rupture

Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to...

Nevro announces two late-breaking data presentations set for NANS 2023

Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been...

Increased annual stroke rate in Canada underscores need for strong treatments...

A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This...

Imperative Care announces FDA clearance and initial cases with stroke-specific radial...

Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s...

Abbott launches “world’s smallest” implantable, rechargeable SCS system for chronic pain

Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is...

Insightec receives US FDA approval to treat essential tremor patients’ second...

Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro...

Study reveals racial disparity in brain tumour surgeries recommended to US...

A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...

Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy

A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...

Shelley Renowden

Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in...

Study indicates safety of novel transmural access to carotid artery perivascular...

A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model. Geoffrey...

Technological advances could render 3D printing a “major manufacturing tool” for...

3d printing stents
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to...

Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease

Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...

Stryker launches “state-of-the-art” neurovascular lab to accelerate stroke care innovation

Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology...

How do we improve the treatment of stroke patients in the...

  This educational supplement has been sponsored by MicroVention. Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several...

Current literature supports stenting as feasible bailout option after failed thrombectomy

failed thrombectomy rescue stenting
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah...

NeuroNews issue 48 – US

Highlights: With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...

NeuroNews issue 48 – EU

Highlights: With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...

Medtronic Neurovascular partners with Avail to boost real-time connectivity

Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process. The goal of this...

Spinal cord stimulation and other modalities will benefit from greater understanding...

Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned...

Axonics gains Health Canada approval for fourth-generation rechargeable sacral neuromodulation system

Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction. The newly...

IRRAS receives new US FDA 510(k) clearance for next-generation IRRAflow control...

IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on...

Eight winners advance to Phase 2 in Neuromod Prize competition

Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted...

NeuroOne successfully completes feasibility study with OneRF ablation system

NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted...

NeuroNews’ top 10 most popular stories of November 2022

Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent...

Timothy Deer to receive inaugural NANS Presidential Merit Award

Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit...

Study identifies “urgent need” to reduce burden of ischaemic stroke in...

A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions,...

Intraoperative neuromonitoring may drive a new era in spinal cord stimulation...

“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the...

Clinicians urge Scottish government to reverse £7 million thrombectomy funding cut

Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding...

Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access

stroke thrombectomy access disparities
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...

AI demonstrates potential to detect carotid artery disease on duplex ultrasound

A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...

Wise receives US FDA clearance for intraoperative monitoring cortical strip

Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA)...

LuSeed Vascular appoints Robert Stern to board of directors

LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s...

SNIS: Physicians “should not have to choose” between family life and...

The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for...

NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome

NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...

Viz.ai partners with Cercare to support neurovascular clinical decision-making

Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...

Neurologica announces US FDA 510(k) clearance of BodyTom 64

BodyTom 64
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance...

Cerevasc co-founders honoured with Innovation Award at SVIN 2022

Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and...

Swiss parliament votes to accept US FDA-approved medical devices

The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland. A motion...

RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...

rsna 2022
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...

Vesalio appoints VP of US sales, announces publication of “impressive” first-pass...

vesalio
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution...

Abbott to receive multiple CES 2023 awards for neurostimulation and pacemaker...

Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...

Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools

Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...

Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment

Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...

Intermittent stimulation of the DRG produces comparable chronic pain results to...

Intermittent dorsal root ganglion stimulation (DRG-S) has been shown to produce comparable results to continuous stimulation across a two-week period, as reported in Neuromodulation:...

Mainstay announces publication of post-market data from ongoing chronic low back...

Mainstay Medical has announced the publication of data from a single-centre, real-world study with one-year clinical follow-up of patients selected from its ReActiv8-C study,...

Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions

Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...

Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...

The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...

Why responsive neurostimulation is garnering “wide interest” from the epilepsy field

To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...

Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry

cerenovus svin 2022
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...

SPR Therapeutics debuts occipital nerve stimulation data at ASRA 2022

At the 21st annual American Society of Regional Anesthesia (ASRA) pain medicine meeting (17–19 November 2022, Orlando, USA), SPR Therapeutics is highlighting five new data sets demonstrating...

Route 92 Medical announces expansion to new manufacturing site in Utah

Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...

IRRAS announces commercial US partnership with Medtronic for IRRAflow system

IRRAS recently announced it has signed a sales agency agreement to promote its IRRAflow system in the USA with Medtronic. During the initial pilot phase of this...

World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches

While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...

Collavidence: A global project looking to break down longstanding barriers in...

collavidence
As per its own mission statement, Collavidence wants to “make medical research collaboration and funding easier, more accessible and more transparent”, paying mind to...

Contego completes enrolment of PERFORMANCE II carotid stent trial

Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed. PERFORMANCE II is intended to evaluate the safety and effectiveness...

CVRx launches new version of neuromodulation device intended to treat heart...

CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...

Brainomix and Visionable announce partnership to optimise UK stroke care pathway

Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...

New study finds 85% of aneurysms identified by Viz ANEURYSM had...

Viz.ai has shared highlights from new data set to be presented at next week’s Society of Vascular and Interventional Neuroradiology (SVIN) annual meeting (16–19...

Optically generated focused ultrasound shows promise for non-invasive brain stimulation

In a new paper published in Light: Science and Applications, a team of scientists and engineers led by Ji-Xin Cheng and Chen Yang (Boston...

Rapid ICH receives new US FDA clearance with “highest sensitivity and...

Rapid ich
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...

Positive animal-model results with ABILITY BCI are “important step” towards human...

The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...

Insightec announces sustained and significant tremor improvement with focused ultrasound thalamotomy

Insightec has announced the publication of what it claims is the largest prospective, long-term follow-up study to date of unilateral magnetic resonance imaging-guided focused...

NeuroNews’ top 10 most popular stories of October 2022

A common theme surrounding last month's World Stroke Day (29 October) was the fact that, while acute ischaemic stroke therapies may have advanced markedly...

New CMS telehealth designation extends coverage of Abbott’s NeuroSphere virtual clinic

As part of its Medicare Telehealth Services List, the US Centers for Medicare and Medicaid Services (CMS) will continue to cover the use of...

iVascular launches new neurovascular portfolio with four CE-marked devices

Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...

BAOCHE trial results supporting thrombectomy for basilar artery stroke published in...

baoche trial
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...

Medtronic study finds post-stroke protocols “vary significantly” between community hospitals and...

Medtronic has announced the first results from its DiVERT clinical study, which showed that post-stroke workflow protocols and cardiac monitoring vary significantly across community...

World Stroke Day: WSO to launch new Stroke Certification initiative

On World Stroke Day (29 October 2022), the World Stroke Organization (WSO) has announced the launch of a new programme that aims to drive...

BE FAST: Physicians advocate greater public awareness on World Stroke Day

On World Stroke Day 2022 (29 October), US physicians from the Get Ahead of Stroke campaign are urging the public to embrace the “simple...

Synchron to begin COMMAND trial enrolment at University of Pittsburgh

Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA. The COMMAND trial is an early...

Medtronic announces launch of neurovascular Co-Lab platform

Medtronic has announced the launch of its neurovascular Co-Lab platform, which is designed to accelerate "urgently needed" innovation in stroke care and treatment. The company...

NICO raises US$12.5 million in oversubscribed investment round

NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...

NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...

NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...

Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart...

Bruce Ovbiagele, associate dean and professor of neurology at the University of California San Francisco (UCSF; San Francisco, USA) and chief of staff at...

Philips to highlight latest advances in stroke care at 2022 World...

Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...

Vessel-wall imaging could hold the key in “known yet understudied” phenomenon...

Following the publication of a case report in Topics in Magnetic Resonance Imaging, researchers from Malaysia have indicated that the use of vessel-wall imaging...

Axoft launches ‘soft’ brain-implant technology, gains US FDA Breakthrough Device designation

Neurotechnology start-up Axoft has launched and announced US Food and Drug Administration (FDA) Breakthrough Device designation for its brain-machine interface (BMI) technology intended to...

Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments

Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...

Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial

Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...

RAPID Aneurysm programme shows positive early performance in retrospective study

RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...

Vesalio announces EU MDR certification of neurovascular product lines

vesalio
Vesalio has announced EU Medical Device Regulation (MDR) certification of its product lines—achieving this “significantly ahead” of its May 2023 deadline, according to a...

Systematic review finds “strong evidence base” supporting deep brain stimulation for...

Deep brain stimulation (DBS) can halve the symptoms of severe obsessive-compulsive disorder (OCD), according to the findings of a pooled data analysis of available...

New white paper details early experience with ABILITY brain-computer interface

A new white paper, released by the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), reveals the first neural signals recorded by the ABILITY...

Nevro announces US FDA approval of HFX iQ system to personalise...

Nevro Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS)...

Society of Vascular and Interventional Neurology announces 40-second stroke awareness challenge

The Society of Vascular and Interventional Neurology (SVIN) has said it wants to create awareness around stroke events leading up to World Stroke Day...

NeuroPace announces first patient implant in NAUTILUS pivotal study

NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...

Neuspera announces first successful Nuvella system implant in second phase of...

Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...

IRRAS announces educational webinar series alongside Jacobs Institute and University of...

IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...

Researchers develop injectable biomaterial with potential in endovascular aneurysm treatment

Researchers in the USA have developed an injectable, ‘toothpaste-like’ biomaterial that may offer promise in the treatment of intracranial aneurysms as an alternative to...

Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control

Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...

Process times and regional variation are main areas of concern for...

Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...

NICO announces completed enrolment in trial evaluating new ICH intervention approach

NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...

Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures

Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...

Nevro announces first global manufacturing operation with Costa Rica expansion

Nevro Corporation announced recently that the US Food and Drug Administration (FDA) has approved its manufacturing operations in Costa Rica for the production of its proprietary...

US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care

Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...

NeuroNews’ top 10 most popular stories of September 2022

The latest and greatest in neurointerventional clinical research buzzed our readers in September, with new studies on dual antiplatelet therapy (DAPT) duration, radial versus...

Microvention celebrates 25 years in neuroendovascular technologies with ‘Patient’s Day’

Microvention, a wholly owned subsidiary of Terumo Corporation, today celebrated its 25-year anniversary in the neuroendovascular technologies industry. The capstone of Microvention’s 25th anniversary celebration...

Wallaby/phenox officially announces global launch of Pegasus HPC stent system

Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...

HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial

In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...

Magnus receives US FDA clearance for SAINT neuromodulation system in severe...

Magnus Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its SAINT neuromodulation system for the treatment of...

Flow diverting, stenting and beyond—HPC technology offers “limitless” potential in neurointervention

This advertorial is sponsored by phenox. Following the publication of a study assessing the use of Hydrophilic Polymer Coating (HPC) technology with the p64 MW...

UK NICE publishes interventional procedure guidance for ReActiv8 restorative neurostimulation

Mainstay Medical has announced that the National Institute for Health and Care Excellence (NICE), a public body of the UK Department of Health, has...

SWIFT-DIRECT sub-analysis finds effect of bridging thrombolysis is preserved over time

A recent sub-analysis of the SWIFT-DIRECT trial, which is published in the Journal of NeuroInterventional Surgery (JNIS), has found “no evidence” that the effect...

Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine

Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...

Vesalio announces US FDA approval of NeVa VS to treat cerebral...

Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...

Similar complication rates observed following DAPT discontinuation within and past 90...

The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...

Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system

Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...

Sheba and Thomas Jefferson to build “state-of-the-art” neuroscience centre in Israel

Sheba Medical Center, which is located in Ramat Gan, Israel and claims to be the country’s largest medical centre, has announced a major collaboration...

The inevitable growth of neurovascular robotics: Improved precision today, potential remote...

This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA. The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...

Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters

The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...

Onward reports positive study results in restoring arm and hand function...

Onward Medical recently announced that the Up-LIFT pivotal study evaluating its non-invasive spinal cord stimulation (SCS) ARC-EX therapy achieved its primary effectiveness endpoint of...

CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment

Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...

Increased coiling rate suggests shift towards endovascular techniques during COVID-19 pandemic

A global study published in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) has revealed that, while ruptured aneurysm clipping rates remained largely unchanged,...

How AI, automation, robotics and other innovations in ultrasound are improving...

Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...

Axonics announces first patient implants in Canada with recharge-free sacral neuromodulation...

Axonics has announced the first patient implants in Canada with Axonics F15, the company’s newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system. The University...

Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire

Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....

Self-administered tDCS reduces knee osteoarthritis pain in older adult patients

Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...

Penumbra announces European launch of RED reperfusion catheters for stroke care

Penumbra announced today that its RED reperfusion catheters have secured a CE mark and are now commercially available in Europe. The catheters are part of...

Isil Saatci

Isil Saatci has been practising interventional neuroradiology (INR) in Ankara, Turkey for almost the entirety of her career—initially at Hacettepe University, where she also...

Nevro announces positive coverage updates for treatment of painful diabetic neuropathy...

Nevro Corporation has announced that US health plan Aetna has updated its spinal cord stimulation (SCS) coverage policy to explicitly cover painful diabetic neuropathy...

Insightec announces financing up to US$200 million to support continued growth

Insightec has announced that it has signed a credit facility for up to US$200 million with affiliates of existing shareholders, Perceptive Advisors and Community Fund....

NeuroNews’ top 10 most popular stories of August 2022

In August, NeuroNews’ most read stories included new clinical data on a number of neurovascular technologies, physician viewpoints on a “historic” neurointerventional procedure in...

Neurofenix completes US$7 million Series A funding for digital stroke and...

Neurofenix has raised US$7 million in Series A funding via a round led by AlbionVC, with additional participation from HTH, InHealth Ventures, and existing...

Brainomix awarded tender to roll out AI imaging software across all...

Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...

Vesalio gains CE-mark approval for new “one-of-a-kind” NeVa NET thrombectomy device

Vesalio has today announced receipt of CE-mark approval for commercialisation of its new NeVa NET, which the company claims is the “first and only”...

Gimer Medical granted IDE approval for spinal cord stimulation system

Gimer Medical today announced that the company’s spinal cord stimulation (SCS) system was granted conditional investigational device exemption (IDE) approval by US Food and...

NeuroNews issue 47 – US

Highlights: Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...

NeuroNews issue 47 – EU

Highlights: Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...

New-look ESMINT congress to reflect on ISAT study and prioritise international...

After a long period of uncertainty triggered by a worldwide pandemic, the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...

Abnormal DW-MRI foci “significantly more frequent” with radial versus femoral access

A prospective analysis of 200 consecutive diagnostic cerebral angiograms has indicated that the number of diffusion-weighted magnetic resonance imaging (DW-MRI) restriction foci was “significantly...

Theranica secures US$45 million through Series C funding round

Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...

CereVasc announces first treatment in US trial evaluating eShunt for normal-pressure...

CereVasc today announced completion of the first eShunt procedure in the USA as part of a pilot study involving normal-pressure hydrocephalus (NPH) patients. The study is being conducted...

AiM unveils prototype of MRI-compatible neurosurgical robot, receives Sontag Foundation funding

AiM Medical Robotics has announced the unveiling of a magnetic resonance imaging (MRI)-compatible prototype of its “industry-first” robotics platform, a company press release states,...

First US Stentrode implant heralds new field in neurointerventional surgery

first command implant
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...

New data demonstrate effectiveness of Penumbra system and RED catheters for...

Penumbra today announced initial INSIGHT registry data showing that its RED reperfusion catheters were successful in removing all clot types—and, additionally, results of sub-analyses...

Imperative Care announces positive, single-centre data on distal occlusion stroke treatment

Imperative Care recently announced that new data evaluating the utility of its Zoom stroke solution were presented at the 16th congress of the World...

IRRAS announces first patient treatments in DIVE study at Mount Sinai...

IRRAS has announced the initial patient treatments with the company's IRRAflow system within Mount Sinai Health System (New York, USA). Thus far, two patients suffering...

Abbott gains US FDA approval for Proclaim Plus spinal cord stimulation...

Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360...

Ybrain receives Translational Research Award for tDCS technology

Ybrain recently received the Translational Research Award at this year's Neuroergonomics and NYC Neuromodulation Conferences (28 July–1 August, New York City, USA) for its transcranial direct...

J Mocco becomes 27th Society of NeuroInterventional Surgery president

J Mocco, an endovascular neurosurgeon at Mount Sinai in New York City, USA has been named the 2022 president of the Society of NeuroInterventional...

Progress update on Women in Neuromodulation: Achievements and obstacles

women neuromodulation update
In light of recent progress made in alleviating gender disparities within the neuromodulation field, Magdalena Anitescu (Chicago, USA), Anne Fennimore (Boca Raton, USA), Kiran...

Minnetronix makes “world’s first” expandable brain port available to neurosurgical markets

Minnetronix Medical’s first product, which the company says was conceptualised, developed, US Food and Drug Administration (FDA)-cleared and manufactured internally, is now fully commercialised...

Randomised data support use of tDCS in Parkinson’s patients with Pisa...

Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...

Vena Medical announces first global thrombectomy procedures with Balloon Distal Access...

Vena Medical has announced the successful treatment of the first five patients in the world using its Vena Balloon Distal Access Catheter (BDAC) at...

SNIS 2022: WEB flow diverter shown to be safe and effective...

The Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) saw research involving the Woven EndoBridge (WEB; Microvention/Terumo) device disclosed for the...

RAAS inhibitors shown to reduce risk of intracranial aneurysm rupture in...

A multicentre study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of renin-angiotensin-aldosterone system (RAAS) inhibitors—a...

SyncThink secures CE mark for EYE-SYNC digital health platform

SyncThink announced today that it has gained CE-mark certification for its EYE-SYNC technology, affirming conformity to the European Medical Device Regulation (MDR). EYE-SYNC will...

NeuroOne submits special 510(k) to US FDA for Evo sEEG electrode

NeuroOne Medical Technologies has announced the submission of a special 510(k) to the US Food and Drug Administration (FDA) for its stereoelectroencephalography (sEEG) electrode...

CereVasc announces US FDA approval for second IDE study of eShunt...

CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...

Taiwan’s FDA approves first autonomous neurosurgical navigation robot from Brain Navi

NaoTrac, a CE-certified neurosurgical navigation robot from Brain Navi Biotechnology, has achieved approval from Taiwan's Food and Drug Administration (TFDA), and submission to the...

Phase one winners announced in US$9.8 million Neuromod Prize competition

The National Institutes of Health (NIH) Common Fund has named eight winners of the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate...

NeuroNews’ top 10 most popular stories of July 2022

Updates from two major neurointervention events, the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) and LINNC Paris (30 May–1...

Silk Vista Baby demonstrates safety and effectiveness in PICA aneurysm treatment

Following a retrospective review of databases from multiple different centres, researchers have reported the safe and effective use of the Silk Vista Baby (Balt)...

Abbott introduces Canada’s first remote neuromodulation patient-care technology

Abbott recently announced the Health Canada licensing of NeuroSphere virtual clinic, a remote programming technology that the company claims is the first of its kind...

SNIS 2022: Late-breaking data bolster evidence supporting thrombectomy for BAO stroke

Late-breaking research presented at the recent Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) has shown that thrombectomy procedures can...

Stroke Association calls for 24/7 thrombectomy service across the UK

A new report released by the UK Stroke Association warns that, if thrombectomy rates remain at 2020/21 levels, a total of 47,112 stroke patients...

SNIS 2022: COVID-19 may increase stroke risk in younger patients and...

Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...

SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...

A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...

SNIS 2022: Direct triage to Level 1 stroke centres reduces time...

Implementing severity-based field triage leads to faster treatment and less disability for stroke patients, according to late-breaking research presented recently at the Society of...

SNIS 2022: Neuroendovascular robotics could improve safety of complex procedures

Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented at the Society of NeuroInterventional Surgery’s...

Imperative Care announces positive real-world data associated with Zoom stroke solution...

Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society...

Mitchell Elkind to join AHA leadership team as chief clinical science...

The American Heart Association (AHA) has announced that Mitchell Elkind (Columbia University, New York City, USA), long-time volunteer of the organisation and renowned neurologist,...

Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...

Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...

Rapid Medical gains US FDA clearance for “smallest and only” adjustable...

rapid medical tigertriever 13
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...

Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...

Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...

RapidAI receives US FDA clearance for Rapid Hyperdensity

Rapid ich
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...

“Spectacular” unilateral proptosis treatment receives LINNC Paris Best Case Award

An “interesting case” of unilateral proptosis in a 14-year-old girl, treated using a hybrid approach via direct external carotid artery (ECA) puncture, was presented...

New study to assess intracranial haemorrhage detection with flat-detector versus multi-slice...

siemens healthineers SPINNERS
The SPINNERS study, which has just been announced by Siemens Healthineers, will evaluate the diagnostic accuracy of non-contrast flat-detector computed tomography (CT) compared to...

Robotics, AI and other innovations in stroke and aneurysm care on...

Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...

Cerenovus announces clinical data and product showcases ahead of SNIS 2022

cerenovus svin 2022
Cerenovus, part of Johnson & Johnson MedTech, will showcase its latest innovations in stroke care at the 2022 Society of NeuroInterventional Surgery (SNIS) annual...

Synchron announces first human brain-computer interface implant in the USA

Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...

Saluda Medical presents data on 24-month holistic response to spinal cord...

Saluda Medical has announced that Steven Falowski (Argires-Marotti Neurosurgical Associates of Lancaster, Lancaster, USA) recently presented late-breaking 24-month data from the company’s EVOKE study at...

Imperative Care announces poster presentations on Zoom stroke solution at SNIS...

Imperative Care has announced that new data from studies evaluating the utility of the Zoom stroke solution for the treatment of ischaemic stroke will...

NeuroNews’ top 10 most popular stories of June 2022

In-depth discussions regarding a “landmark” study in medium vessel occlusion (MeVO) stroke, and the first thrombectomy procedures with a novel balloon guide catheter device,...

Rare disease variant specific to East Asian patients increases post-EVT reocclusion...

Among people who received endovascular mechanical thrombectomy to remove a large vessel occlusion (LVO), those with a rare genetic disease variant found primarily in people...

Large-scale prospective studies required to elucidate antithrombotic medication outcomes

The world of interventional neuroradiology will likely need to follow the cardiology field and conduct large-scale prospective studies in order to move away from...

Abbott receives Breakthrough Device designation to explore DBS in managing severe...

Abbott recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to investigate the use of its deep brain...

NICO announces new distributor for neurosurgery markets in Australia and New...

NICO Corporation recently announced that it has partnered with Imedcare, an Australia-based supplier and distributor of devices, as its distributor for the neurosurgery markets in the medical...

NeuroOne announces first clinical case using Evo sEEG electrode technology

NeuroOne Medical Technologies today announced that the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode was recently performed by Robert Gross at Emory University in...

High-frequency SCS demonstrates “substantial improvement” in health-related quality of life outcomes

Nevro Corporation has announced that the complete 12-month results from the SENZA-PDN randomised controlled trial (RCT), including health-related quality of life outcomes in patients with...

Neuromod publishes new data showing improvement of tinnitus symptoms with bimodal...

Neuromod Devices has published the results of the company's TENT-A2 (Treatment evaluation of neuromodulation for tinnitus—stage A2) clinical trial in Scientific Reports via a...

NeuroVasc announces first patient treated in clinical trial evaluating novel stent...

NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational device exemption (IDE) clinical study, the ENVI randomised controlled...

Sham-controlled studies indicate effectiveness of TMS for negative schizophrenia symptoms

A systematic review and meta-analysis published in Nature Schizophrenia has concluded that data from sham-controlled studies to date indicate the effectiveness of transcranial magnetic...

Current literature suggests promise held by electrical stimulation therapies for cerebral...

Electrical stimulation technologies, and in particular spinal cord stimulation (SCS) and sphenopalatine ganglion stimulation, offer a promising adjunct to existing therapies for cerebral vasospasm...

AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments

The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...

Tenecteplase shown to be effective for acute ischaemic stroke in large...

In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...

Alarming trends and alarmist myths: What is the link between COVID-19...

covid-19 stroke relationship
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...

COVID-19 “did not affect stroke care quality or outcomes” in largest...

In one of the first studies to investigate the overall quality of care and outcomes of stroke care for non-COVID-19 hospitalised patients during the...

Neuspera Medical announces second phase of SANS-UUI clinical trial with Nuvella...

Neuspera Medical recently announced it will begin enrolment in its pivotal clinical trial, SANS-UUI—a single-arm investigational device exemption (IDE) study that will enrol 145 patients...

Valencia Technologies announces first commercial implantation of eCoin tibial neurostimulator

Valencia Technologies Corporation has announced in a press release that it has completed the “world's first” commercial implantation of its eCoin leadless tibial neurostimulator,...

Stimwave announces sale of business and secures US$40 million in financing

Stimwave Technologies Incorporated (Stimwave) recently announced that it has reached an agreement to sell substantially all of its assets to Kennedy Lewis Management LP...

MicroTransponder raises US$53 million and appoints new CEO

funding
MicroTransponder has closed an oversubscribed US$53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and...

Neuromodulation offers hope for patients with long-COVID

With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...

Carthera receives FDA Breakthrough Device designation for Sonocloud-9 system

Carthera announced today that its Sonocloud-9 system has been listed as a Breakthrough Device by the Center for Devices and Radiological Health (CDRH) at...

MIVI Neuroscience names Waleed Brinjikji as new medical director

Next-generation neurointerventional medical device innovator MIVI Neuroscience has announced that Waleed Brinjikji (Mayo Clinic, Rochester, USA) has joined the company as its medical director. “The...

Carotid stenting demonstrates comparable short- and long-term results to endarterectomy

Pooled patient-level data from more than 2,500 asymptomatic, non-octogenarian subjects have shown that carotid artery stenting (CAS) achieved comparable short- and long-term results to...

Pedro Lylyk

Pedro Lylyk’s work and achievements in the neurosurgical field have spanned several decades, and range from a momentous intracranial stent placement in 1996, to...

INS 2022: Late-breaking research indicates safety of deep brain stimulation in...

Deep brain stimulation (DBS) offers a safe therapy option for reducing chorea in patients with Huntington’s disease, but it remains to be seen whether...

First Emboguard experiences reveal “excellent trackability and ease of use” in...

Having been launched earlier this year, the Emboguard balloon guide catheter (Cerenovus) was recently used in mechanical thrombectomy procedures for the first time. David...

Silk Road to evaluate TCAR in standard surgical risk patients with...

Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...

INS 2022: Occipital nerve stimulation shows clinical benefit and safety in...

A randomised controlled trial (RCT) presented at the International Neuromodulation Society (INS) congress (21–26 May 2022, Barcelona, Spain) has demonstrated significant and clinically relevant...

AHA statement highlights need for more data on sex differences in...

A new American Heart Association (AHA) scientific statement has highlighted the need for more data about sex differences in the use of and response...

Multicentre study indicates WEB flow disrupters can safely be used in...

As per the findings of a multicentre, retrospective study, use indications for the Woven EndoBridge (WEB) intrasaccular flow disruption device (Microvention/Terumo) can be safely...

High responder rates, substantial pain relief and no explants among key...

Nevro Corporation has announced the results from data presentations at the American Diabetes Association (ADA) 82nd Scientific Sessions (3–7 June 2022, New Orleans, USA) supporting the use of...

It takes two: The benefits of direct ‘double stentriever’ thrombectomy in...

This advertorial, sponsored by Medtronic, is intended for readers outside of the USA. Mechanical thrombectomy may be the standard of care for acute ischaemic strokes...

MindMaze and University of Auckland partner on trial evaluating immersive intervention...

MindMaze—in partnership with the University of Auckland (Auckland, New Zealand)—has announced a new study that will aim to show the merits of early, immersive...

Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients

tdcs autism
In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...

Route 92 publishes data demonstrating 80% first-pass effect with novel thrombectomy...

Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint...

Neuros Medical announces completion of 90-day primary endpoints in QUEST pivotal...

Neuros Medical has announced the completion of its QUEST pivotal trial’s 90-day primary endpoints, according to a company press release. QUEST outcomes will remain...

NeuroNews’ top 10 most popular stories of May 2022

A myriad of potentially groundbreaking clinical trials were in focus on NeuroNews throughout the month of May. A novel device in pain management, a...

Research indicates low stroke risk and benefit of medication alone in...

The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be...

Axonics files FDA premarket approval supplement for fourth-generation rechargeable neurostimulator

Axonics has filed a premarket approval (PMA) supplement with the US Food and Drug Administration (FDA) for its fourth-generation rechargeable sacral neuromodulation (SNM) implantable...

Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke...

Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...

Nevro announces upcoming presentation of new SENZA-PDN clinical data

Nevro Corporation has announced that data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—which the company says is the largest RCT to...

DISTAL: A landmark trial looking to elucidate endovascular treatment outcomes in...

distal study mevo
In December 2021, University Hospital Basel (Basel, Switzerland) enrolled the first patient worldwide in the DISTAL study—a multicentre randomised controlled trial (RCT) evaluating the...

INS 2022: Dorsal horn dendrite stimulation offers “true breakthrough” in pain...

A novel approach to spinal cord stimulation (SCS), which involves targeting the dorsal horn dendrite—in contrast with more traditional ‘axonal’ SCS techniques—has been labelled...

Neuromodulation for post-stroke recovery advancing on several fronts

As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...

Charing Cross audience as-yet unconvinced by data supporting transcarotid artery revascularisation

Audience polling during the Acute Stroke Challenges session at this year’s Charing Cross Symposium (CX 2022; 26–28 April, London, UK and virtual) revealed scepticism...

NeuroNews issue 46 – US

Highlights: Late-breaking presentations from the European Stroke Organisation Conference (ESOC) progress clinical data on tenecteplase as an alternative intravenous thrombolysis drug to alteplase, and the...

NeuroNews issue 46 – EU

Highlights: Late-breaking presentations from the European Stroke Organisation Conference (ESOC) progress clinical data on tenecteplase as an alternative intravenous thrombolysis drug to alteplase, and the...

Neuro42 licenses robotic technology from Johns Hopkins University

Neuro42 has announced an exclusive licensing agreement with Johns Hopkins University (Baltimore, USA) for its magnetic resonance (MR)-compatible robot for head, neck and spine...

Treating chronic-stage stroke with hyperbaric oxygen therapy

hbot stroke
Mohammed Elamir (The Villages, USA) and Amir Hadanny (Be'er Ya'akov, Israel) mark this year’s Stroke Awareness Month by discussing hyperbaric oxygen therapy (HBOT)—an emerging...

Adept announces Prone Support product launch

Adept Medical says it has responded to the call from interventional radiologists for a device to comfortably support and manage a patient in the...

Vesalio announces oversubscribed Class A financing

Vesalio recently announced that it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors,...

ESOC 2022: New study links gut microbiota strains with more severe...

A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut...

FDA approves launch of “largest clinical trial to date” for tDCS...

Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation device to treat depression at home, has received full...

Medtronic announces first implant in study evaluating investigational, closed-loop neurostimulator

Medtronic today announced the first patient implant in a clinical study of its investigative, closed-loop, implantable neurostimulator. The ‘Evaluation of long-term patient experience with...

Stroke in young people may be associated with increased likelihood of...

The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...

First commercial Vivistim patient set to begin paired vagus nerve stimulation...

MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...

Vesalio announces completion of enrolment in acute ischaemic stroke IDE study

vesalio
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...

STAR network and Avail Medsystems partner to aid remote physician collaboration

Avail Medsystems has announced that it has entered into a partnership with the Stroke Thrombectomy and Aneurysm Registry (STAR), led by Alejandro Spiotta (Medical...

Dolphin vagal nerve stimulator gains Health Canada nod for ‘long-haul’ COVID-19...

Health Canada recently authorised the Dolphin vagal nerve stimulator to treat symptoms in patients with COVID-19 ‘long-haul’ symptoms (long haulers). Long haulers experience a wide variety of aftereffects...

NeuroNews’ top 10 most popular stories of April 2022

Novel neurovascular technologies, from robotics, to microcatheters, to artificial intelligence (AI), were among the hottest topics featured on NeuroNews in April. A momentous company...

Synchron enrols first patient in US COMMAND study of endovascular brain-computer...

Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...

ATTENTION results indicate “we have finally conquered the basilar artery” with...

attention evt basilar
This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...

Artificial intelligence tutoring outperforms expert instructors in neurosurgical training

Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...

Carotid stenosis in women: Should the approach differ?

carotid stenosis women
The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...

NeuroPace announces first treatment in pivotal study evaluating RNS system in...

NeuroPace has announced that the first patient was recently treated in the RESPONSE clinical trial, which is evaluating the safety and effectiveness of the...

ESOC 2022: ‘Brain-age’ biomarkers predict stroke recovery more accurately than chronological...

Stroke experts have identified how radiomics—an emerging, image-quantifying technology—can be used to extract biomarkers from clinical brain magnetic resonance imaging (MRI) scans in stroke...

Study findings encourage direct EVT approaches over bridging thrombolysis in select...

A retrospective study involving more than 200 patients has indicated that ‘bridging thrombolysis’ may not be associated with improved functional outcomes in stroke patients...

Millimetric implant offers promising alternative to opioids or surgery in pain...

Using a one-millimetre-sized wireless implant to stimulate peripheral nerves from within blood vessels has the potential to treat neuropathic pain that is resistant to...

“Largest ever” study on traumatic brain injury highlights global inequality in...

Neurosurgery experts from the University of Cambridge (Cambridge, UK) have led what is claimed to be the largest ever study examining the surgical management...

Recommended use of SCS in neuropathic pain has not led to...

Only a small proportion of neuropathic pain patients in England who are potentially eligible for spinal cord stimulation (SCS) have received this intervention over...

Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions

Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...

Baptist Health South Florida to acquire ZAP-X gyroscopic radiosurgery platform

ZAP Surgical Systems announced today that Baptist Health South Florida (Miami, USA) will acquire the ZAP-X gyroscopic radiosurgery platform for cranial stereotactic radiosurgery (SRS)....

First patient treated in clinical trial of CereVasc’s eShunt system for...

CereVasc has announced treatment of the first patient in its clinical study of the eShunt system in patients with normal-pressure hydrocephalus (NPH). Following approval from Argentina's...

MIT engineers develop joystick-operated robot to help surgeons treat stroke remotely

Engineers from the Massachusetts Institute of Technology (MIT) in Cambridge, USA have developed a telerobotic system to enable surgeons to quickly and remotely treat...

GT Medical Technologies to present clinical data on GammaTile brain tumour...

GT Medical Technologies announced today that new data on the company's innovative GammaTile therapy for patients with operable brain tumours will be presented via...

Medtronic names Laura Mauri as new chief scientific, medical and regulatory...

Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...

Abbott upgrades NeuroSphere myPath app for patient monitoring in neuromodulation trials

Abbott today announced that it has launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality intended to help doctors...

International Neuromodulation Society announces “Innovations in Neuromodulation” event at May congress

With an educational event entitled “Innovations in Neuromodulation”, the International Neuromodulation Society (INS) will attempt to bring together industry leaders, innovators and investors to...

Microvention announces enrolment of first patient in STRAIT study evaluating new...

Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the successful completion of its first patient enrolment in a multicentre, prospective, observational study...

Stimwave launches FREEDOM series with trial evaluating PNS in chronic knee...

Stimwave Technologies has announced the launch of its level-one FREEDOM clinical trial series—which consists of multicentre, prospective, randomised trials that monitor chronic pain patients’...

Wallaby acquires phenox to accelerate global expansion in neurovascular space

Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments. The acquisition is...

Women less likely to return to work after severe stroke, new...

According to new research published in Stroke, about one third of people who had a severe ischaemic stroke—and underwent a mechanical thrombectomy to remove...

UK stroke patients among thousands left waiting more than one hour...

In March 2022, more than 390,000 people who called 999 with emergencies including suspected stroke waited for an average of over one hour for...

NeuraLace announces two new patents for Axon neuropathic pain therapies

NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...

Axonics announces comprehensive launch of F15 recharge-free SNM system

Axonics today announced the comprehensive launch of the Axonics F15 across the USA. The newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system also...

Bendit receives FDA 510(k) clearance for 0.021-inch steerable microcatheter

Bendit Technologies has received US Food and Drug Administration (FDA) 510(k) clearance of its Bendit21 microcatheter for treatment in the neuro, peripheral and coronary...

Preliminary data indicate improved neurological outcomes with alteplase versus placebo

As per early findings from the CHOICE randomised controlled trial (RCT), the use of adjunct, intra-arterial alteplase—among patients with large vessel occlusion (LVO) acute...

Corindus relocates Massachusetts headquarters to accommodate company growth

Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the...

CX 2022: Acute stroke programme seeks to evaluate study data and...

Barbara Rantner (Munich, Germany) previews the Acute Stroke Challenges programme at CX 2022—a two-hour session featuring several debates and audience polls on carotid disease...

Viz.ai raises US$100 million in Series D funding to expand AI...

Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, as per a company press release. The Series D round, which...

Michael Chen

michael chen
Michael Chen—a neurointerventionist and professor of Neurology, Neurosurgery and Radiology at Rush University Medical Center in Chicago, USA—speaks to NeuroNews to provide insight on...

Guidewire-less neurovascular navigation system shows promise in rabbit aneurysm model

A new concept for navigating the neurovasculature, performed without the aid of a guidewire, has demonstrated its ability to be manoeuvred through tortuous vessels,...

Aidoc gains FDA 510(k) clearance for AI-supported triage and notification of...

Aidoc has received US Food and Drug Administration (FDA) 510(k) clearance for the triage and notification of brain aneurysm—which affects one in 50 people...

NeuroNews’ top 10 most popular stories of March 2022

Industry-fronting experts from the worlds of neurointerventional surgery and neuromodulation alike weighed in on a number of key topics throughout the month of March....

Cefaly publishes study data indicating effectiveness of e-TNS migraine treatment

Cefaly Technology has announced the results of a clinical study demonstrating that two-hour treatment with its external trigeminal nerve stimulation (e-TNS) Cefaly device is...

Study data indicate positive outcomes with “exciting new treatment option” in...

Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...

London clinic becomes first in UK to offer new drug-free Alzheimer’s...

The London Alzheimer’s Clinic on Harley Street (London, UK) has become the first clinic in the UK to offer transcranial pulse stimulation (TPS)—a “revolutionary”...

Why robotics holds the key to the future of stroke treatment

robotics stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...

Radial access is not just a new toy—it has come to...

This advertorial is sponsored by Medtronic. Upon gaining CE-mark approval in September of last year, the Rist radial access system (Medtronic) became the first dedicated...

Biomodex launches clear cartridges for neurovascular surgery training

Biomodex has announced the launch of new clear cartridges for use with all of its EVIAS (Endovascular intracranial aneurysm system) and EVIAS Plus stations for preprocedural...

NeuroNews issue 45 – US

Highlights:  Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients The pros and cons of...

NeuroNews issue 45 – EU

Highlights:  Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients The pros and cons of...

Implantable brain-computer interface enables completely locked-in patient to communicate

Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...

Synchron announces long-term safety results with Stentrode device for severe paralysis

synchron stentrode safety
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...

Sonocloud technology demonstrates safety and therapeutic potential in Alzheimer’s patients

sonocloud alzheimer's
Carthera has announced today the publication of results from an investigator-sponsored pilot clinical trial evaluating safety and efficacy using its Sonocloud technology in patients...

Cerus Endovascular receives FDA clearance for 027 microcatheter products

Cerus Endovascular has received US Food and Drug Administration (FDA) 510(k) clearance for its 027 microcatheters, available in two lengths, expanding on a product...

Survey uncovers “far-reaching” impact of pandemic on patients with chronic back...

A new survey commissioned by Medtronic and conducted by public opinion research firm The Harris Poll has found that 44% of current chronic back...

Medtronic announces first patient implants of investigational TNM therapy for bladder...

Medtronic recently announced the first patients have been implanted in the TITAN 2 pivotal study—which will evaluate the safety and efficacy of its investigational...

High-frequency SCS drives impactful outcomes for non-surgical refractory back pain patients

senza-nsrbp
Following the recent introduction of key data supporting the use of high-frequency spinal cord stimulation (SCS) in the treatment of non-surgical refractory back pain...

AAN issues new guidance on preventing second stroke in patients with...

In patients with intracranial atherosclerosis, the use of medications and exercise is more beneficial in preventing a second stroke than placing a stent in...

Stimwave Technologies provides update on reimbursement of chronic pain therapies

Stimwave Technologies has provided an update on recent reimbursement-related progress pertaining to its chronic pain therapies—which include implantable spinal cord stimulation (SCS) and peripheral...

AiM Medical Robotics raises US$3.4 million to accelerate MRI-compatible robotics platform

AiM Medical Robotics recently announced that it has raised US$3.4 million in seed funding, led by IQ Capital and Surrey Capital Partners. Other investors include The...

Zeta Surgical secures US$5.2 million to enhance AI-driven neurosurgical technologies

Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta,...

Pushing the boundaries of aneurysm detection, monitoring and care with AI

ai cerebral aneurysm
Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...

Lower frequencies may improve outcomes of pain treatment with dorsal root...

Lower frequencies of dorsal root ganglion stimulation (DRG-S) may be more effective in the treatment of neuropathic pain—as per a late-breaking presentation from Guilherme...

The pros and cons of radial access in neurointerventional surgery

radial access neurointerventional surgery
As the adoption of radial access across the world of neurointerventional surgery begins to pick up pace, Pascal Jabbour and Kareem El Naamani (Thomas...

Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas

A new strategy using telehealth to monitor blood pressure at home for several months immediately after a stroke had a positive impact on patient engagement and blood...

Multiple daily doses of iTBS provide no additional benefit in treatment-resistant...

In patients with treatment-resistant depression (TRD), multiple sessions of intermittent theta-burst stimulation (iTBS) do not accelerate responses to the therapy, nor do they improve...

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...

New technology enables option for neurosurgeons to avoid pinning patients’ heads...

Following the introduction of its BrainPath navigation probe adapter at the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA), medical device innovator NICO Corporation claims...

Axonics receives FDA approval for new recharge-free sacral neuromodulation system

Axonics has announced that the US Food and Drug Administration (FDA) has approved its newly developed, long-lived, recharge-free sacral neuromodulation (SNM) implantable neurostimulator, the...

Rapid Medical announces Eitan Havis as international president

Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular...

Valencia Technologies announces FDA approval of eCoin therapy for urinary urge...

Valencia Technologies Corporation has announced that the US Food and Drug Administration (FDA) has granted premarket approval of its eCoin leadless tibial neurostimulator for...

AI, cost reductions and more represent bright future for neuromodulation industry

On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...

Registration opens for 15th International Neuromodulation Society congress in Barcelona

At the International Neuromodulation Society (INS) 15th world congress (21–26 May 2022; Barcelona, Spain), researchers from over 40 countries will present plenary lectures and...

Multiple-modality spinal cord stimulation demonstrates sustained improvement in chronic pain outcomes

A spinal cord stimulation (SCS) system capable of simultaneously delivering multiple treatment modalities has produced a sustained improvement in outcomes in a randomised controlled...

NeuroNews’ top 10 most popular stories of February 2022

Highlights from the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA)—predominantly relating to mechanical thrombectomy studies—grabbed our readers’ attention throughout February. New...

NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...

NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...

First patient implanted in clinical study assessing hypoglossal nerve stimulation for...

LivaNova has announced the first patient has been implanted as part of an investigational device exemption (IDE) clinical study, dubbed OSPREY (Treating obstructive sleep apnea using...

Accuray announces NICE endorsement for radiosurgery treatment of trigeminal neuralgia

Accuray has announced that the National Institute for Health and Care Excellence (NICE) has endorsed the use of its radiosurgery technology for trigeminal neuralgia—strengthening...

Microvention announces treatment of first US patient with FRED X flow...

Microvention, a subsidiary of Terumo, has announced the first US clinical case using its next-generation flow diverter, the FRED X device, at Thomas Jefferson University Hospital...

Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm

Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...

Lack of evidence among challenges that must be overcome to realise...

In spite of the clinical successes observed to date, a lack of high-level safety and efficacy evidence, among other current challenges and limitations, must...

FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system

Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...

Medtronic receives FDA approval for InterStim X system for bladder and...

Medtronic has announced receipt of approval from the US Food and Drug Administration (FDA) for its new, recharge-free InterStim system—with the device being made...

Children with severe stroke may fare better if treatment includes mechanical...

Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...

Neuromod welcomes study demonstrating safety and efficacy of Lenire device in...

Neuromod Devices has welcomed the findings of an independent study performed at the German Hearing Center at Hannover Medical School (Hannover, Germany), which found...

ISC 2022: New study finds better outcomes in patients treated at...

When comparing outcomes for acute ischaemic stroke patients treated at various levels of stroke centres, patients who received care at comprehensive stroke centres (CSC) or thrombectomy-capable...

Single-patient study offers promise for individualised depression treatment with DBS

Despite its small sample size, a study in which a patient received closed-loop, deep brain stimulation (DBS) therapy has demonstrated positive clinical outcomes and...

Myopro shows clinically significant gains in motor function for chronic moderate-to-severe...

Myomo has announced that new research measuring the benefits of its Myopro myoelectric orthosis found “statistically significant improvements” in a number of motor function...

New player in stent retriever space demonstrates non-inferiority to Solitaire device

A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...

Study shows positive impact of new in-app feature on Nerivio REN...

A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...

Newer clot-busting medication may someday increase time window for stroke treatment

In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...

Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment

Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...

Imperative launches Zoom POD aspiration tubing for use in stroke treatments

Imperative Care has announced the launch of its Zoom POD aspiration tubing—the company’s latest innovation in elevating stroke care. This is the newest addition...

Nevro announces publication of 12-month data on high-frequency SCS for non-surgical...

Nevro Corporation has announced online publication of 12-month data from the SENZA-NSRBP randomised controlled trial (RCT) in Journal of Neurosurgery: Spine. These data show that...

ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...

Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...

NovaGuide intelligent ultrasound found to significantly improve right-to-left shunt detection

NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the company’s autonomous NovaGuide intelligent ultrasound is three times more...

New data presented at ISC 2022 further validate real-world impact of...

Data from several new studies presented at the recent International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA) further validate the “best-in-class” sensitivity and...

NeuroOne releases successful long-term recording data with novel electrode technology

NeuroOne Medical Technologies has announced that it successfully completed initial preclinical, long-term testing of recording capabilities on its thin-film platform electrode technology. In test...

Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke

Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...

Mechanical thrombectomy shown to restore more function than medication alone following...

severe stroke thrombectomy
A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...

NeuroNews’ top 10 most popular stories of January 2022

An exclusive interview with the North American Neuromodulation Society (NANS) president piqued the interest of NeuroNews’ readers through the first month of the year,...

Perfuze raises €22.5m in Series A funding for novel acute ischaemic...

Perfuze announced today that it has closed a €22.5 million Series A investment round—the proceeds from which will be used to drive the next...

CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...

CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...

Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...

Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...

Few cases and short timeframe required to overcome learning curve with...

A retrospective analysis of a prospectively maintained database has found that robot-assisted carotid artery stenting (CAS) is both safe and effective. Writing in Neurosurgical...

Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...

The findings of a randomised controlled trial (RCT) have indicated that accelerated intermittent theta-burst stimulation (iTBS), administered to the left dorsolateral prefrontal cortex (DLPFC), is an...

Earl Slee joins Vesalio as new board observer and senior advisor...

vesalio
Vesalio has announced the addition of Earl Slee as a board observer and senior advisor to the company, effective immediately. According to a company...

Vena balloon distal access catheter gains Health Canada medical device licence

Vena Medical has announced the first Health Canada medical device licence for its new product, the Vena balloon distal access catheter, which combines the...

Reducing disability and death: What is next for stroke triage and...

stroke triage transport
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...

Updated medical policy expands patient access to Abbott’s DRG stimulation technology

Abbott announced today that UnitedHealthcare (UHC)—the largest private health insurance company in the USA—has updated its ‘Implanted electrical stimulator for spinal cord’ medical policy...

Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment

Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...

Researchers pave way for adaptive DBS treatment after identifying OCD-associated brain...

In an effort to improve treatment for obsessive-compulsive disorder (OCD), a team of researchers has—for the first time, according to a Brown University (Providence,...

Galvani Bioelectronics announces first investigational treatment of rheumatoid arthritis using splenic...

Galvani Bioelectronics has announced that the first patient with rheumatoid arthritis (RA) has been treated through stimulation of the splenic nerve using its novel...

Rebus Esper platform leveraged to create “cell atlas” of brain vasculature...

Rebus Biosystems, an Illumina Ventures-backed life science technology firm, has announced the publication of a study in Science highlighting its Rebus Esper platform’s ability to spatially...

FDA issues two final guidances for including patient perspectives in medical...

The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.   As...

NANS 2022: New 18-month data show durability of high-frequency SCS for...

senza-pdn study
This year’s North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) saw 18-month data from SENZA-PDN—a randomised controlled trial (RCT) evaluating the...

Brainomix launches e-Stroke 11 to enhance stroke network communications and workflow

Brainomix has announced the launch of e-Stroke 11, the latest version of the company's AI-powered stroke imaging platform. According to a Brainomix press release,...

Salim Hayek

Salim Hayek is chief of the Division of Pain Medicine at University Hospitals of Cleveland and a professor in Case Western Reserve University’s Department...

Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research

Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...

NIH launches first phase of US$9.8 million competition to accelerate development...

The National Institutes of Health (NIH) has launched the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate the development of neuromodulation therapies....

Bendit announces first-in-human use of Bendit21 neurovascular catheter in the USA

Bendit Technologies has announced the successful first use in the USA of its Bendit21 neurocatheter in a life-saving treatment. The case was completed at the University...

Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal...

cerus study
Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...

Large real-world analysis deems Nerivio safe and effective in migraine treatment

Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...

Nevro announces clinical data reinforcing significant and durable benefits of 10kHz...

Nevro Corporation has announced the results from data presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) supporting...

Medtronic announces results showing meaningful pain relief using DTM SCS endurance...

Medtronic has announced three-month results from an on-label, prospective, multicentre study showing meaningful pain relief using DTM SCS endurance therapy—a modified, lower-energy variation of the...

NANS 2022: Telehealth to play key role in improving patient access...

telehealth neuromodulation
COVID-19 may have held a defining role in the “rebirth” of telehealth and remote care models in the USA, but their utility in improving...

Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression

saint depression treatment
Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...

American Academy of Neurology provides ethical guidance on consent for people...

The American Academy of Neurology (AAN) has issued a position statement for neurologists on how to navigate consent issues for people who have experienced acute ischaemic...

First patient implanted in integrated spinal fusion and DRG stimulation proof-of-concept...

SynerFuse has announced the first implantation in the company's proof-of-concept study evaluating the safety and tolerability of simultaneously implanting spinal fusion hardware and a dorsal...

Evasc Neurovascular announces enrolment of first patient in French eClips study

Evasc Neurovascular has announced enrolment of the first patient in its eClips safety, feasibility and efficacy study (EESIS-FR) in France. The study will be...

Dedicated primary care can reduce stroke risk in seniors by more...

ChenMed has announced results from a three-year study of nearly 60,000 patients, showing 22% lower incidence of primary stroke among those having benefitted from...

FDA grants Breakthrough Device designation to Wavegate for StimuLux system

Wavegate Corporation has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for its StimuLux optical reflectometry system for closed-loop...

Medtronic announces schedule for sponsored presentations at NANS 2022

Medtronic has announced its schedule for presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA). According to a press...

Study indicates aneurysm embolisation strategy can be optimised using 3D-printed, patient-specific...

Endovascular neurosurgery rehearsals using 3D-printed, patient-specific aneurysm models have demonstrated the ability to optimise embolisation strategy, as per the findings of a study published...

NeuroNews’ top 10 most popular stories of December 2021

In the lead up to the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA), the topic of neuromodulation featured prominently among...

Mainstay Medical announces positive efficacy and safety outcomes from ReActiv8-B trial

Mainstay Medical has announced the publication of two-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, which are published in Neuromodulation:...

Saluda announces sustained, long-term pain relief results with closed-loop SCS in...

Saluda Medical today announced long-term results from its double-blind, Level 1 EVOKE trial, which have been published in JAMA Neurology and demonstrate superior, sustained pain...

Boston Scientific to present new data on advances in chronic pain...

Boston Scientific has announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA)....

NeuroNews issue 44 – US

Highlights:  Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox) The latest clinical data on endovascular therapy for...

NeuroNews issue 44 – EU

Highlights:  Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox) The latest clinical data on endovascular therapy for...

iMediSync unveils “world’s first” integrated wireless brain EEG solution at Consumer...

iMediSync recently showcased its comprehensive electroencephalogram (EEG) solution, designed to perform brain screening and predictive analysis of potential mental conditions in just 10 minutes,...

Enabling new possibilities in stroke treatment with Stream technology

perflow stream devices
This advertorial is sponsored by Perflow. The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...

Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...

Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....

Abbott announces expanded MRI compatibility for Proclaim XR spinal cord stimulation...

Abbott has announced that the US Food and Drug Administration (FDA) has approved new, expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...

Patient assent and lack of evidence among key ethical concerns identified...

paediatric deep brain stimulation
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...

Worldwide stroke rates dip slightly over time, but overall numbers remain...

The worldwide incidence and mortality rates for stroke decreased slightly from 1990 to 2019, but the overall numbers remain high—especially in high- and middle-income...

Current gaps and barriers in patient access to spinal cord stimulation

spinal cord stimulation patient access
Maricela Schnur (St Luke’s Hospital, Duluth, USA) highlights a handful of socioeconomic disparities, racial differences, and psychological and psychiatric factors, that currently present difficulties...

CyberKnife robotic radiosurgery system approved for treatment of trigeminal neuralgia in...

Accuray has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market the CyberKnife robotic radiosurgery system for the treatment of...

BRAIN 2021: In silico clinical trials likely to play complementary role...

in silico clinical trials
In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...

US physicians “among nation’s first” to implant neurostimulator technology for advanced...

Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...

ClaroNav receives Chinese regulatory clearance for Navient neuro-navigation system

ClaroNav Kolahi—a subsidiary of ClaroNav—has received regulatory clearance from the National Medical Products Administration (NMPA) to market and sell its Navient cranial model in...

Time savings, cost reductions and improved patient outcomes all key benefits...

artificial intelligence stroke care
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...

First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy...

BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...

NeuroNews’ top 10 most popular stories of November 2021

The latest technologies and research breakthroughs in neuromodulation feature prominently among our top stories for November, while two momentous announcements from the neurosurgery field—courtesy...

Mouse study suggests neuromodulation of certain nerve cells can help regenerate...

Johns Hopkins Medicine researchers say they have new evidence from mouse experiments that manipulating certain nerve cells, or the genes that control them, with...

CereVasc announces publication of first-in-human case report with eShunt system

CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...

Passive recharge burst SCS provides sustainable improvements in pain and psychosocial...

Passive recharge burst spinal cord stimulation (B-SCS) can alleviate pain intensity and psychological distress, and improve physical function and health-related quality of life out...

MicroTransponder receives best new product award for Vivistim system

MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...

FluxWear to debut wearable neuromodulation device at 2022 Consumer Electronics Show

FluxWear has announced that it will be demonstrating its first product at the Consumer Electronics Show (CES) early next year (5–8 January 2022, Las...

AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...

aurora meta-analysis
Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...

New protocol may reduce need for psychological assessments prior to neuromodulation...

Researchers at Toronto Western Hospital in Canada have proposed a protocol that may precede in-person assessments prior to patients receiving neuromodulation therapies. Their protocol...

Wyss Center, Inselspital Bern announce clinical trial of long-term brain monitoring...

epios brain-monitoring technology
As part of a recently announced clinical trial, brain signal recording with the Wyss Center for Bio and Neuroengineering’s novel brain-monitoring technology, its subscalp...

Nevro announces three key data publications on novel painful diabetic neuropathy...

Nevro has announced three clinical data publications on treating painful diabetic neuropathy (PDN) with 10kHz spinal cord stimulation (SCS) therapy—including 12-month data from the...

Incidence of brain complications among hospitalised COVID-19 patients revealed in global...

The largest multi-institutional international study to date on brain complications associated with COVID-19 has found that approximately one in 100 patients hospitalised following SARS-CoV-2...

White matter hyperintensities may hold key to identifying long-term harm in...

A new study has found that brain scans taken during the lifetimes of athletes in contact sports, compared to changes in their brains at...

Large prospective study demonstrates high efficacy and low mortality rates with...

Diversion-p64 study
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...

Intranasal delivery of microrobots could trigger new possibilities in treating neurological...

A research team in South Korea has developed and successfully implanted a microrobot device into the brain tissue of mice through the intranasal pathway,...

SedLine-guided general anaesthesia may reduce post-carotid endarterectomy delirium

Masimo has announced the findings of a prospective study published in Frontiers in Neurology in which Na Xu and colleagues at Capital Medical University in Beijing,...

Antibiotic envelopes appear safe and effective in decreasing SCS surgical site...

scs surgical infection
Antibiotic impregnated envelopes appear to be a safe and effective modality for decreasing surgical site infection risks in spinal cord stimulation (SCS) implantation, according...

Robocath successfully performs first carotid stenting in France with R-One robot

Robocath today announced its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on 16 November...

Accuray announces two decades of clinical data on CyberKnife robotic radiotherapy...

Accuray has announced the publication of more than two decades of globally-driven clinical data supporting the use of its CyberKnife robotic radiotherapy platform for the delivery...

NeuroNews’ top 10 most popular stories of October 2021

New data on stroke rehabilitation and chronic migraine therapy caught the eye of NeuroNews' readers in October, as did notable discussions from industry-leading events...

Viz.ai debuts AI-powered cerebral aneurysm detection technology at SVIN 2021

At this year’s Society of Vascular and Interventional Neurology annual meeting (SVIN 2021; 17–20 November, Phoenix, USA and virtual), Viz.ai introduced Viz ANX, a...

BlueWind Medical completes patient enrolment in OASIS study

BlueWind Medical has announced the successful completion of patient enrolment in the OASIS pivotal clinical study that will assess the company’s innovative Renova iStim...

Hispanic stroke patients experience poorer post-thrombectomy outcomes than white counterparts

hispanic stroke patients
A study conducted by neurology researchers at University of Texas Southwestern (UTSW) Medical Center has found lower-quality functional outcomes for Hispanic ischaemic stroke patients...

Cascade device provides the best of both worlds in treating cerebral...

This advertorial is sponsored by Perflow. The Cascade Net (Perflow)—a non-occlusive remodelling net used in the treatment of cerebral aneurysms—is the first and only device...

NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...

NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...

Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...

New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...

Insightec announces FDA approval of Exablate Neuro device to treat Parkinson’s...

exablate neuro fda approval
Insightec has announced that the US Food and Drug Administration (FDA) has approved the Exablate Neuro device for treating advanced Parkinson's disease patients suffering from...

Return to work and depressive symptoms in young stroke survivors

post-stroke depression
Matthias Volz (University of Kassel, Kassel, Germany), Simon Ladwig and Katja Werheid (both Humboldt-Universität zu Berlin, Berlin, Germany) discuss the burden of post-stroke depression...

Nevro announces plans to appeal jury decision in spinal cord stimulation...

nevro patent infringements
Nevro Corporation has provided an update on its position following a Delaware jury’s decision to award Boston Scientific US$20 million over patent infringements. The...

Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...

rapid medical tigertriever 13
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...

Rune Labs and Medtronic partner to improve understanding of neurostimulation with...

medtronic rune labs
Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and global healthcare...

New study finds e-Stroke software shortens treatment times and improves functional...

A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...

Magnus Medical announces Breakthrough Device designation for novel depression treatment and...

Magnus Medical has announced that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its individualised, rapid-acting, non-invasive...

Increased experience associated with shorter procedure times and better reperfusion rates...

operator experience thrombectomy
Increasing levels of experience in performing mechanical thrombectomies have been associated with shorter procedural duration and better reperfusion rates in a multicentre study—with the...

World Stroke Day 2021: Get Ahead of Stroke campaign pushes for...

world stroke day 2021
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...

World Stroke Day 2021: Survey finds 65% of hospitals worldwide do...

On the eve of World Stroke Day (29 October), the World Stroke Organization (WSO) has called for urgent improvements to the treatment of stroke...

Phenox expands acute ischaemic stroke portfolio with global launch of pRESET...

Phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...

Biomodex launches synthetic clot product for neurovascular training

Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...

SPR Therapeutics announces expanded FDA clearance for SPRINT peripheral nerve stimulation...

SPR Therapeutics has obtained clearance from the US Food and Drug Administration (FDA) of a broader indication for the usage of its SPRINT peripheral...

Study indicates safety and efficacy of remote electrical neuromodulation in chronic...

Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...

North Carolina updates stroke triage and transport protocol

North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...

Neuvotion secures more than US$1 million in seed funding to commercialise...

Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...

MindMaze partners with Royal Buckinghamshire Hospital to bring novel stroke rehab...

mindpod uk
MindMaze Healthcare has announced the first UK partnership for its novel MindPod platform to target cognitive and motor restoration in stroke patients. This new partnership...

NeuroNews’ top 10 most popular stories of September 2021

Highlights from this year's European Stroke Organisation Conference (ESOC 2021; 1–3 September, virtual), Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021;...

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...

Wyss Center announces CE mark for Epios Cloud brain data visualisation...

The Wyss Center has announced CE mark Class I medical device approval for its Epios Cloud software—a web-based application for the online storage, processing...

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

neurovasc envi-sr trial china
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...

Stroke study reveals optimal timing and intensity for arm and hand...

stroke rehabilitation study
A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...

High-frequency SCS takes the stage to relieve chronic pain from diabetic...

scs diabetic neuropathy
Following the recent approval of the Senza system (Nevro) by the US Food and Drug Administration (FDA), Erika A Petersen (Little Rock, USA) discusses the...

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...

Indian health ministry approves Exablate Neuro focused ultrasound platform

exablate neuro fda approval
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...

Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...

cello ii catheter
Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...

FAST SCS innovation producing results “rarely seen before” in the world...

This advertorial is sponsored by Boston Scientific and is only intended for readers in Europe. Fast-acting sub-perception therapy (FAST™)—a novel innovation in the field of...

NeuroOne successfully completes feasibility study of Evo ablation electrode

NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...

LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...

evt neuroprotection
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...

Else Charlotte Sandset

else charlotte sandset
Else Charlotte Sandset is a consultant neurologist in the Stroke Unit of the Department of Neurology at Oslo University Hospital, and chair of the...

Rhaeos awarded US$4 million NIH grant to expand sensor technology for...

Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...

ESMINT 2021: COATING study “badly needed” to assess surface modification of...

coating study phenox
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...

Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...

neuros quest study
Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...

Study indicates efficacy of hyperbaric oxygen therapy in reversing Alzheimer’s activators

A new study, published in the peer-reviewed medical journal Aging, marks the first time non-pharmaceutical clinical exploration has proved efficacious in reversing the main...

Novel teleproctoring platform successfully used for neuroendovascular fellowship training

neuroendovascular teleproctoring
A novel augmented reality (AR) platform (Proximie) has been successfully used to teleproctor a neuroendovascular fellow during complex interventional and diagnostic procedures. That is...

CRISP study indicates clinical benefit of non-paraesthesia-based approaches in burst SCS...

crisp study scs
The CRISP (Comparison of paraesthesia mapping to anatomic midline-based burst programming strategies) study, published in Neuromodulation: Technology at the Neural Interface, has found that...

Sensome begins first-in-human trial of AI-powered stroke guidewire

sensome clot out
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...

NeuroNews issue 43 – US

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies – including new insights on the Flow redirection endoluminal device (FRED;...

NeuroNews issue 43 – EU

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies - including new insights on the Flow redirection endoluminal device (FRED;...

TCAR may be associated with favourable outcomes for treatment of restenotic...

tcar restenotic carotid lesions
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies

flow diverter devices
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....

Neuromod Devices appoints Diarmuid Flavin as COO to boost expansion of...

Diarmuid Flavin
Neuromod Devices has announced the appointment of Diarmuid Flavin as chief operating officer (COO). Flavin brings more than 25 years of global leadership experience...